Diagnosis and Outcomes of Placental Accretism
ConditionPlacenta Accreta
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-44
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The goal of this observational study is to evaluate the diagnostic ability of the main criteria currently adopted for the diagnosis of placenta accreta and to define the maternal outcomes in terms of complications of the different management strategies currently adoptable when placental accretism is suspected.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18 years and 44 years
Pregnant women with suspected placental accretism
Acquisition of informed consent form
Disqualifiers
None
Trial population
Patients with suspected placental accretism/percretism followed at the Outpatient Clinics of the Division of Obstetrics and Prenatal Age Medicine at IRCCS-AOUBO Policlinico di Sant'Orsola and participating centers.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Frequency of correspondence between prenatal diagnosis and intra-operative finding of placental accretism
disappearance of the hypoecogenaretroplacental stria, lacunae placental vasculature, hypervascularization of the utero-vesical interface, interruption/irregularity of the bladder will be assessed by ultrasound
Time frame
Up to 1 month post-partumSecondary outcomes
1
Frequency of maternal complications (Surgical site infection)
Post-operative haemorrhage and haemotransfusion, infection of the surgical site will be assessed by blood count with leucocyte formula, coagulation tests (thrombin time, thromboplastin time and fibrinogen), PCR (C-reactive protein), blood cultures
Time frame
Up to 1 month post-partumSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov